ZeccaCMerliniADisantoG, et alHalf-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study. Mult Scler. 2018; 24: 167–174.
2.
TanakaMKinoshitaM.Daily fingolimod administration may cause lymphopenia but alternate-day administration may be too little to inhibit disease activity. J Neuroimmunol2015; 288: 69.
3.
TanakaMParkKTanakaK.Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia. Mult Scler2013; 19: 1244–1245.
4.
TanakaMTanakaK.Dose reduction therapy of fingolimod for Japanese patients with multiple sclerosis: 24-month experience. Clin Exp Neuroimmunol2014; 5: 383–384.
